Rhythm Pharmaceuticals, Inc.
NASDAQRYTM enters its June 24 earnings report with a notable split: short sellers have been quietly trimming positions, while options traders have swung to their most bullish stance in months. The options picture is the sharpest signal this week. The put/call ratio has collapsed to 0.32, nearly 2.7 standard deviations below its 20-day average of 0.47 — meaning call demand is running far…
Snapshot as of 22 Jun 2026
RYTM enters its June 24 earnings report with a notable split: short sellers have been quietly trimming positions, while options traders have swung to their most bullish stance in months. The options picture is the…
Rhythm Pharmaceuticals enters the back half of the week trading 10% higher, powered by a strong Q1 earnings beat that sent analysts scrambling to revise their models upward — while shorts hold their ground at the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RYTM — free to start on ORTEX.
Sign up for free →Open RYTM on ORTEX